Nutex Health (NASDAQ:NUTX) Reaches New 1-Year High Following Earnings Beat

Nutex Health Inc. (NASDAQ:NUTX) shares hit a new 52-week high on Wednesday following a stronger than expected earnings report. The stock traded as high as $182.00 and last traded at $153.47, with a volume of 256101 shares. The stock had previously closed at $125.93.

The company reported $2.56 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $2.71. The firm had revenue of $211.79 million for the quarter, compared to the consensus estimate of $81.09 million. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%.

Wall Street Analyst Weigh In

NUTX has been the subject of several analyst reports. Maxim Group boosted their target price on Nutex Health from $75.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday, April 8th. Benchmark boosted their target price on Nutex Health from $150.00 to $300.00 and gave the stock a “buy” rating in a research note on Thursday.

Insider Buying and Selling

In related news, CFO Jon Christian Bates bought 1,000 shares of the stock in a transaction that occurred on Tuesday, April 8th. The stock was purchased at an average cost of $81.81 per share, with a total value of $81,810.00. Following the purchase, the chief financial officer now directly owns 4,888 shares of the company’s stock, valued at $399,887.28. This trade represents a 25.72% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. 38.52% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the business. Bank of America Corp DE boosted its position in shares of Nutex Health by 6,590.3% during the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock worth $66,000 after acquiring an additional 2,043 shares in the last quarter. Northern Trust Corp acquired a new position in shares of Nutex Health during the 4th quarter worth about $200,000. Baader Bank Aktiengesellschaft acquired a new position in shares of Nutex Health during the 4th quarter worth about $206,000. Millennium Management LLC acquired a new position in shares of Nutex Health during the 4th quarter worth about $213,000. Finally, World Investment Advisors acquired a new position in shares of Nutex Health during the 4th quarter worth about $217,000. 5.32% of the stock is owned by institutional investors and hedge funds.

Nutex Health Trading Up 9.4%

The company has a 50-day moving average price of $99.20 and a 200-day moving average price of $60.12. The firm has a market capitalization of $960.55 million, a price-to-earnings ratio of -18.51 and a beta of -0.10. The company has a debt-to-equity ratio of 3.36, a quick ratio of 1.74 and a current ratio of 1.77.

Nutex Health Company Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.